Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.

Mostra altre versioni (1)

BACKGROUND: Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and duration. The need to provide effec...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Cipriani, A, Boso, M, Barbui, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2009

Documenti analoghi

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
di: Barber, S, et al.
Pubblicazione: (2017)

Does the addition of a second antipsychotic drug improve clozapine treatment?
di: Barbui, C, et al.
Pubblicazione: (2009)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
di: Cipriani, A, et al.
Pubblicazione: (2013)

Retrospective evaluation of sociodemographic and clinical characteristics of patients with schizophrenia receiving clozapine monotherapy and clozapine combined with different antipsychotics
di: E. Yıldız, et al.
Pubblicazione: (2024-04-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
di: Jari Tiihonen, et al.
Pubblicazione: (2012-01-01)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
di: Hülya Ertekin, et al.
Pubblicazione: (2016-08-01)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
di: Barbui, C, et al.
Pubblicazione: (2011)

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
di: Zoe Harrison, et al.
Pubblicazione: (2021-01-01)

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
di: Nosè, M, et al.
Pubblicazione: (2009)

Comparison effects of clozapine, ECT and combination ECTand clozapine on resistance treatment of schizophrenia(Double blind)
di: S.H. Hosseini, et al.
Pubblicazione: (2006-01-01)

Combination treatment with second generation antipsychotics other than clozapine
di: C. Schmidt-Kraepelin
Pubblicazione: (2021-04-01)

Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
di: Magdalena Jiménez-Cornejo, et al.
Pubblicazione: (2016-12-01)

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia
di: Júlio César Menezes Vieira, et al.
Pubblicazione: (2024-06-01)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
di: Miquel Bioque, et al.
Pubblicazione: (2020-01-01)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
di: Leucht, S, et al.
Pubblicazione: (2013)

Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
di: Wei Zheng, et al.
Pubblicazione: (2016-01-01)

Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey.
di: Barbui, C, et al.
Pubblicazione: (2013)

Consideration of Clozapine in Patients With Treatment Resistant Schizophrenia
di: Niema Moazzami, et al.
Pubblicazione: (2024-06-01)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
di: B. Jorge, et al.
Pubblicazione: (2021-04-01)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
di: Leucht, S, et al.
Pubblicazione: (2013)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
di: Leucht, S, et al.
Pubblicazione: (2013)

Clozapine of treatment resistant-schizophrenia: what are the actual advances?
di: Rodrigo A Bressan, et al.
Pubblicazione: (2001-06-01)

Combining ECT and clozapine in the treatment of clozapine-refractory schizophrenia and schizoaffective disorder – a pilot study
di: L Koen, et al.
Pubblicazione: (2008-12-01)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
di: H. Becerra Darriba
Pubblicazione: (2021-04-01)

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia
di: S. Khouadja, et al.
Pubblicazione: (2021-04-01)

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings
di: C. Casetta, et al.
Pubblicazione: (2024-02-01)

Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review.
di: Mazzucco, S, et al.
Pubblicazione: (2008)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
di: Vjekoslav Peitl, et al.
Pubblicazione: (2023-04-01)

A False Case of Clozapine-Resistant Schizophrenia
di: J. P. Maia-de-Oliveira, et al.
Pubblicazione: (2010-01-01)

Characterising the evolution of antipsychotic polypharmacy and clozapine prescribing patterns in schizophrenia patients during psychiatric hospitalisations
di: J. Lagreula, et al.
Pubblicazione: (2022-06-01)

Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
di: Octavian Vasiliu
Pubblicazione: (2022-11-01)

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
di: O.O. Khaustova, et al.
Pubblicazione: (2024-04-01)

Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
di: Mitesh Kumar, et al.
Pubblicazione: (2017-01-01)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
di: Lewis, S, et al.
Pubblicazione: (2006)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
di: Lewis, S, et al.
Pubblicazione: (2006)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
di: S Lewis, et al.
Pubblicazione: (2006-05-01)

Conventional vs. atypical antipsychotic medications.
di: Barbui, C, et al.
Pubblicazione: (2006)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
di: V. Arienti, et al.
Pubblicazione: (2023-03-01)

Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
di: L. Orsolini, et al.
Pubblicazione: (2022-06-01)

Clozapine: A special case of an atypical antipsychotic
di: Elina Marinho
Pubblicazione: (2024-04-01)